Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of eslicarbazepine acetate as adjunctive therapy for partial seizures in elderly patients
KCT0000512Phase 3Recruiting
- Sponsor
- BIAL
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of eslicarbazepine acetate in epilepsy, sponsored by BIAL. Started May 2012; status: recruiting.
02
Drugs
eslicarbazepine acetate
03
Conditions
epilepsy
Beyond the preview
Go deeper on KCT0000512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000512.